Pharmaceuticals & Biotech

NORMI™ Establishes Medical Advisory Board to Strengthen Assessment & Remediation Standards

Board Led by Environmental Illness Expert, Dr. Andrew Heyman, MD, Brings Clinical Insight to Mold Remediation Practices Abita Springs, LA – The National Organization of Remediators and Microbial Inspectors (NORMI™) proudly announces the formation of its Medical Advisory Board, chaired … Continue reading →

Philippines’ Leading Government Financial Institution, DBP, Teams Up with Innovative Biotech Startup AA Biotek to Advance Sustainable Agriculture and Environmental Solutions

San Fernando City, La Union, Philippines – April 17, 2025 – The Department of Agriculture (DA, Philippines) through the Development Bank of the Philippines (DBP) has officially announced a strategic financial partnership with pioneering biotechnology startup AA Biotek Enterprises OPC. … Continue reading →

Power Metallic (OTCQB: PNPNF | TSX.V: PNPN): An Undervalued Critical Metals Stock Alongside HTZ, SMX, TGL, CHRO – Trading Under $5

Power Metallic Mines Inc. (TSX-V: PNPN) (OTCBB: PNPNF) (Frankfurt: IVV) has reported new drill results from its Winter 2025 campaign at the Tiger Zone, returning shallow polymetallic hits and confirming early signs of Lion-style, copper-dominant mineralization in this high-priority area. … Continue reading →

Patient Monitoring Devices Market is Expected to Reach $71.1 billion | MarketsandMarkets™

North America holds the largest share of 34.0% of the Patient Monitoring market The global patient monitoring devices market, valued at US$45.7 billion in 2022, is forecasted to grow at a robust CAGR of 8.0%, reaching US$48.5 billion in 2024 … Continue reading →

US Medical Aesthetics Market worth US$16.38 billion by 2030 with 13.6% CAGR

US medical aesthetics market is segmented into clinics, hospitals, and medicals spas, beauty centers, and home care settings . In 2025, pharmaceutical and biotechnology firms accounted for the largest share among end users driven by rising demand for minimally invasive … Continue reading →

US Radiotherapy Market worth US$2.49 billion by 2030 with 4.6% CAGR

US radiotherapy market is segmented into external beam radiotherapy, and internal beam radiotherapy/brachytherapy technologies. In 2025, external beam radiotherapy technologies accounted for the largest share among end users because of a number of significant reasons. Prominent players in the Radiotherapy … Continue reading →

US Ultrasound Market worth US$3.82 billion by 2030 with 7.6% CAGR

Some key factors propelling the segment expansion are increasing prevalence of cardiovascular disease across major US healthcare markets, widespread adoption in diagnosis and treatment of urological disorders and rising incidence of osteoarthritis. Prominent players in the ultrasound market include Philips … Continue reading →

Post-operative Cataract Surgery Inflammation Market Growth to Accelerate in Forecast Period (2023-2032), DelveInsight Analyzes | Mallinckrodt Pharma, Salix Pharma, GlaxoSmithKline, Pfizer Inc.

The Key Post-operative Cataract Surgery Inflammation Companies in the market include – Mallinckrodt Pharmaceuticals, Salix Pharmaceuticals, GlaxoSmithKline plc., Pfizer Inc., ASKA Pharmaceutical Co., Ltd., Bausch Health, Johnson & Johnson Services, Inc., Janssen Global Services, Takeda Pharmaceutical, Merck & Co., Inc., … Continue reading →

Neurotrophic Keratitis Market to Expand Significantly by 2034, States DelveInsight Report | Oyster Point Pharma, Recordati Rare Diseases, MimeTech, Claris Biotherapeutics, ReGenTree, BRIM Biotech

The Key Neurotrophic Keratitis Companies in the market include – Oyster Point Pharma, Recordati Rare Diseases, MimeTech, Claris Biotherapeutics, ReGenTree, BRIM Biotechnology Inc., Dompé Farmaceutici S.p.A, Syneos Health, and others. DelveInsight’s “Neurotrophic Keratitis Market Insights, Epidemiology, and Market Forecast-2034″ … Continue reading →

Dry Eye Disease Market Growth Projections 2024-2034: DelveInsight Analysis | Palatin Technologies, Novaliq, mc2 therapeutics

The Key Dry Eye Disease Companies in the market include – Palatin Technologies, Novaliq, mc2 therapeutics, and others. The Dry Eye Disease market is expected to surge due to the disease’s increasing prevalence and awareness during the forecast period. … Continue reading →

Thursday - April 17, 2025

Category Archives: Pharmaceuticals & Biotech